Feasibility of One-Step Sentinel Lymph Node (SLN) Biopsy With Radiolabeled Methylene Blue (IND 70,627)

Completed · Phase 2

Conditions studied: Breast Cancer

In brief

The purpose of this study is to develope a one-step procedure to perform a biopsy of axillary lymph nodes on the same side as the breast tumor in women diagnosed with breast cancer.

Key facts

Study ID

NCT00784849

Run by

Louisiana State University Health Sciences Center in New Orleans

People needed

62

Starts

2004-11-01

Expected to finish

2011-06-01

Last updated by the study team

2012-06-20

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• Stage 0,I, II breast cancer
• Clinical node status N0, N1
• No know allergy to iodine, lymphazurin or methylene blue dyes

You may not qualify if…

• Patient cannot be pregnant or nursing
• Prisoners will not be eligible
• Women under the age of 18 will not be eligible
• Patients with a known allergy to iodine or methylene blue or lymphazurin blue dyes

Where it is running

• University Medical Center — Lafayette, Louisiana, United States
• LSU Interim Hospital — New Orleans, Louisiana, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.